Investment Trusts

The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

Actions
  • Price (GBX)1,040.00
  • Today's Change4.00 / 0.39%
  • Shares traded27.48k
  • 1 Year change+26.98%
  • Beta0.6027
Data delayed at least 20 minutes, as of Jul 23 2024 16:35 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for investment trust price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

The Biotech Growth Trust PLC is a United Kingdom-based investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies. The Company invests approximately 10% in aggregate of the value of its gross assets in other closed-ended investment companies, including investment trusts listed on the London Stock Exchange. The Company invests approximately 15% of the value of its gross assets in any one individual stock at the time of acquisition. Its portfolio of investments across various countries includes Netherlands, the United States of America, Canada, and China. The Company’s alternative investment fund manager is Frostrow Capital LLP.

  • Revenue in GBP (TTM)79.73m
  • Net income in GBP74.60m
  • Incorporated1997
  • Employees0.00
  • Location
    The Biotech Growth Trust PLC25 Southampton BuildingsLONDON WC2A 1ALUnited KingdomGBR
  • Phone+44 203 008 4910
  • Fax+44 203 043 8889
  • Websitehttp://www.biotechgt.com/
More ▼

Profile

Management group(s)OrbiMed Advisor LLC
AIC sectorBiotechnology & Healthcare
ISINGB0000385517
Launch date23 Jun 1997
Share typeOrdinary Share
StructureInvestment Trust
Base currencyGBP

Objective

The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.

Managed by

Josh Golomb, Geoffrey C. Hsu

Management & contract fees

AIFM receives a periodic fee equal to 0.30% p.a. of the market capitalisation up to GBP500m, 0.20% above GBP 500m to GBP 1bn and 0.10% over GBP 1bn. The Investment Manager receives a fee equal to 0.65% p.a. of the net assets. The Agreement may be terminated with not less than 12 months notice.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Castelnau Group Ltd9.98m-7.78m322.38m4.00--1.3942.8332.30-0.0393-0.03930.03960.72580.0464--38.242,495,180.00-3.61---4.18---8.18---77.90------0.1709--133.43--77.19------
Fintel PLC64.90m7.10m324.99m494.0045.833.1627.785.010.06810.06810.62220.9880.4786--6.24131,376.505.468.186.439.71----11.4015.64--20.600.109134.58-2.415.07-27.5520.0444.352.63
CT Private Equity Trust PLC24.80m7.62m325.34m0.0043.520.663858.9813.120.10460.10460.34066.850.0419--10.89--1.2912.981.4114.1935.2385.2730.7383.91----0.188224.67-63.14-5.65-79.22-15.52--14.26
Henderson International Income Trust PLC18.14m12.76m327.77m0.0025.680.9255--18.070.06510.06510.09251.810.0473--4.39--3.334.383.354.5185.2985.6470.3876.59----0.067279.55-54.91-16.03-76.65-27.93--7.10
Nippon Active Value Fund PLC53.13m47.56m328.16m0.005.041.03--6.180.34440.34440.40771.690.2215--25.45--19.83--19.87--97.30--89.52----19.450.00--680.97--833.54------
Sherborne Investors (Guernsey) C Ltd46.86m43.91m329.00m0.007.490.581--7.020.06270.06270.06690.80890.0855------8.014.168.024.1795.5486.5493.7383.52--535.900.0012.96209.49--192.36------
Brooks Macdonald Group plc128.48m6.58m332.74m509.0049.262.2520.782.590.410.418.008.980.7013--4.13252,416.503.598.904.0810.86----5.1212.70----0.030665.551.284.37-22.4826.46-11.729.80
Invesco Bond Income Plus Ltd36.48m31.82m335.87m0.009.581.02--9.210.17880.17880.20561.690.0918--173.28--8.012.7310.873.7094.8485.8287.2476.70--17.170.1363166.53214.89--191.91----2.83
Scottish Oriental Smaller Co's Trust PLC53.44m40.62m336.06m0.008.500.9163--6.291.671.672.1915.500.1367------10.394.7110.394.7893.0386.2276.0269.90----0.0019.50-15.11---29.61----2.48
Baillie Gifford European Growth Trst PLC28.58m25.14m337.21m0.0013.460.742--11.800.07080.07080.07991.280.0644--5.50--5.67-0.18535.68-0.187890.82-101.8587.97-68.24----0.1142--110.14--111.50-----31.74
Biotech Growth Trust PLC79.73m74.60m338.38m0.004.750.9602--4.242.182.182.2110.790.2066--10.60--19.334.0821.574.4494.7575.6093.5772.19----0.11530.00320.3824.49280.6428.73----
abrdn Asian Income Fund Limited16.30m8.74m339.73m0.0040.630.8969--20.850.05270.05270.09662.390.0366--7.97--1.965.422.125.8181.3489.8053.6577.56--6.120.074569.17256.76--151.24----5.13
CT UK Capital and Income Invst Trust PLC45.06m41.17m341.84m0.008.501.01--7.590.39770.39770.43273.330.125--15.65--11.422.3612.402.5393.3181.2891.3876.10----0.071122.95197.7415.90184.6416.81---3.49
Baillie Gifford Shin Nippon PLC-75.99m-81.91m348.18m0.00--0.7917-----0.2616-0.2616-0.24291.48-0.1286-------13.86-2.20-15.64-2.31------------0.00---8,177.23---1,062.68------
Lowland Investment Company P L C33.31m28.66m351.24m0.0012.250.9538--10.550.10610.10610.12331.360.0797--7.55--6.86-0.43077.31-0.457488.33-47.5786.05-82.02----0.0749--193.8727.65181.4332.72--2.97
Fidelity Asian Values PLC6.02m-5.81m354.82m0.00--0.9566--58.96-0.081-0.0810.08385.220.0155--2.11---1.497.44-1.527.545.8886.53-96.56112.46---4.170.0031.46164.7846.31193.0542.36--21.40
Data as of Jul 23 2024. Currency figures normalised to The Biotech Growth Trust PLC's reporting currency: UK Pound GBX

Institutional shareholders

32.09%Per cent of shares held by top holders
HolderShares% Held
Border to Coast Pensions Partnership Ltd.as of 31 Mar 20241.99m6.00%
Rathbones Investment Management Ltd.as of 31 Mar 20241.82m5.50%
Brewin Dolphin Ltd.as of 31 Mar 20241.78m5.38%
Hargreaves Lansdown Asset Management Ltd.as of 01 Apr 20241.42m4.29%
West Yorkshire Pension Fundas of 01 Apr 20241.07m3.23%
Columbia Threadneedle Asset Managers Ltd.as of 01 Apr 2024695.48k2.10%
Legal & General Investment Management Ltd.as of 01 Apr 2024516.45k1.56%
Close Asset Management Ltd.as of 01 Apr 2024511.00k1.54%
Evelyn Partners Investment Management LLPas of 01 Apr 2024439.00k1.33%
BlackRock Investment Management (UK) Ltd.as of 01 Apr 2024382.70k1.16%
More ▼
Data from 31 Mar 2023 - 01 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.